Free dose calculator + concentration chart
However, eligibility for tirzepatide is determined by BMI, presence of weight-related comorbidities, and other medical factors not cholesterol levels alone
The STEP clinical trial programme demonstrated that most gastrointestinal symptoms were mild to moderate in severity and transient, with discontinuation rates due to gastrointestinal adverse events around 47%
Avoid using on wounds, damaged, or sensitive skin
For those considering these medications, working with a healthcare provider is essential to manage side effects, address nutritional needs, and tailor treatment plans effectively
Once you have your LOMN, you may be able to sign up for weight-loss programs